Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone: the role of supplemental human chorionic gonadotropin in the luteal phase**Presented at the Thirty-Ninth Annual Meeting of The American Fertility Society, April 16 to 20, 1983, San Francisco, California.-Reference-Cited by-同舟云学术

Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone: the role of supplemental human chorionic gonadotropin in the luteal phase**Presented at the Thirty-Ninth Annual Meeting of The American Fertility Society, April 16 to 20, 1983, San Francisco, California.

Published:1984-04 Issue:4 Volume:41 Page:546-550
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Weinstein Frederick G.,Seibel Machelle M.,Taymor Melvin L.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference21 articles.

1. The neuroendocrine control of the menstrual cycle;Knobil;Recent Prog Horm Res,1980

2. Pregnancies following chronic intermittent (pulsatile) administration of GnRH by means of a portable pump (“Zyklomat”): a new approach to the treatment of infertility in hypothalamic amenorrhea;Leyendecker;J Clin Endocrinol Metab,1980

3. Ovulation induction and conception using subcutaneous pulsatile luteinizing hormone-releasing hormone;Seibel;Obstet Gynecol,1983

4. Ovulation induction with intermittent subcutaneous LH-RH;Keogh;Lancet,1981

5. The role of ultrasound in ovulation induction: a critical appraisal;Seibel;Fertil Steril,1981

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The hypothalamic-pituitary-luteal axis in women: Effects of long-term orally active opioid antagonist (naltrexone) administration;Journal of Endocrinological Investigation;1997-07

2. From physiology to clinics — 20 years of experience with pulsatile GnRH;European Journal of Obstetrics & Gynecology and Reproductive Biology;1996-04

3. Pulsatile gonadotrophin-releasing hormone (GnRH) treatment in hypogonadotrophic amenorrhoea;Reproductive Medicine Review;1993-07

4. 8 Ovulation induction for luteal phase defects and luteal phase defects after ovulation induction;Baillière's Clinical Obstetrics and Gynaecology;1993-06

5. The luteal phase after ovulation induction with human menopausal gonadotropin and one versus two doses of a gonadotropin-releasing hormone agonist**Supported in part by a grant from Syntex Corporation, Palo Alto, California.;Fertility and Sterility;1993-06